Researchers

Results 121-135 of 135
Issue DateTitleAuthor(s)TypeМp-cat.
2008IPO-trimethylation of histone H3-lysine(9) associated with P210BCR-ABL tyrosine kinase of chronic myeloid leukaemiaMancini, Manuela; Zuffa, Elisa; Veljković, Nevena V.  ; Brusa, Gianluca; Corrado, Patrizia; Corradi, Valentina; Martinelli, Giovanni; Barbieri, Enza; Santucci, Maria AlessandraContribution to periodical
21M21
2008Lipoprotein lipase: A bioinformatics criterion for assessment of mutations as a risk factor for cardiovascular diseaseGlišić, Sanja  ; Arrigo, Patrizio; Alavantić, Dragan  ; Perović, Vladimir R.  ; Prljić, Jelena ; Veljković, Nevena V.  Article
21M21
2007Simple criterion for selection of flavonoid compounds with anti-HIV activityVeljković, Veljko ; Mouscadet, Jean-Francois; Veljković, Nevena V.  ; Glišić, Sanja  ; Debyser, ZegerArticle
21M21
2007The presence of antibodies recognizing a peptide derived from the second conserved region of HIV-1 gp120 correlates with non-progressive HIV infectionĐorđević, Ana  ; Veljković, Milena; Antoni, Sascha; Sakarellos-Daitsiotis, Maria; Krikorian, Dimitrios; Zevgiti, Stella; Dietrich, Ursula; Veljković, Nevena V.  ; Branch, Donald R.Reviews
21M21
2007Novel virtual screening protocol based on the combined use of molecular modeling and electron-ion interaction potential techniques to design HIV-1 integrase inhibitorsTintori, Cristina; Manetti, Fabrizio; Veljković, Nevena V.  ; Perović, Vladimir R.  ; Vercammen, Jo; Hayes, Sean; Massa, Silvio; Witvrouw, Myriam; Debyser, Zeger; Veljković, Veljko ;
Botta, Maurizio;
Article
21a+M21a+
2007Application of the EIIP/ISM bioinformatics concept in development of new drugsVeljković, Veljko ; Veljković, Nevena V.  ; Este, J. A.; Huether, A.; Dietrich, U.Reviews
21aM21a
2006In silico criterion for prediction of effects of p53 gene missense mutations on p53-Mdm2 feedback loopVeljković, Nevena V.  ; Perović, Vladimir R.  Article
23M23
2004Antibodies reactive with C-terminus of the second conserved region of HIV-1gp120 as possible prognostic marker and therapeutic agent for HIV diseaseVeljković, Nevena V.  ; Branch, DR; Metlaš, Radmila; Prljić, Jelena ; Manfredi, R; Stringer, WW; Veljković, Veljko Article
22M22
2004Recombination property of the HIV-1 gp120 genePrljić, Jelena ; Veljković, Nevena V.  ; Veljković, Veljko Article
Mp. category will be shown later
2004Molecular makeup of HIV-1 envelope proteinVeljković, Veljko ; Veljković, Nevena V.  ; Metlaš, RadmilaReviews
Mp. category will be shown later
2003Design of peptide mimetics of HIV-1 gp120 for prevention and therapy of HIV diseaseVeljković, Nevena V.  ; Branch, DR; Metlaš, Radmila; Prljić, Jelena ; Vlahovicek, K; Pongor, S; Veljković, Veljko Article
22M22
2002Precise measurement of chlorine isotopes by thermal ionization mass spectrometryNešković, Olivera M.; Veljković, Nevena V.  ; Veličković, Suzana  ; Deric, AJ; Miljević, Nada R.; Golobočanin, Dušan D.Article
23M23
2001AIDS epidemic at the beginning of the third millennium: time for a new AIDS vaccine strategyVeljković, Veljko ; Metlaš, Radmila; Kohler, Heike; Urnovitz, HB; Prljić, Jelena ; Veljković, Nevena V.  ; Johnson, E; Muller, SContribution to periodical
21a+M21a+
2000Rational for selection of DNA and peptide sequences derived the major envelope protein E2 for development of the HCV diagnostic test kitsVasiljevic, NR; Taseski, JJ; Prljić, Jelena ; Veljković, Nevena V.  Conference Paper
Mp. category will be shown later
1999Identification of an active Chi recombinational hot spot within the HIV-1 envelope gene: consequences for development of AIDS vaccinesPrljić, Jelena ; Veljković, Nevena V.  ; Doliana, Roberto; Colombatti, Alfonso; Johnson, Emmett; Metlaš, Radmila; Veljković, Veljko Article
21a+M21a+